Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.27
-0.11 (-0.42%)
Sep 24, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 28.52 | -16.14 | -140.04 | -262.14 | -311.46 | -206.36 |
Depreciation & Amortization | 2.25 | 4.67 | 1.96 | 0.75 | 0.93 | 0.45 |
Asset Writedown & Restructuring Costs | - | - | - | - | 29.63 | - |
Loss (Gain) From Sale of Investments | -0.95 | -2.09 | -6.9 | -6.99 | -2.25 | 3.45 |
Stock-Based Compensation | 43.55 | 40.36 | 41.73 | 38.81 | 32.68 | 23.89 |
Other Operating Activities | 2.65 | 2.41 | 6.17 | 6.01 | 2.93 | 0.31 |
Change in Accounts Receivable | -48.48 | -73.16 | -47.26 | -17.35 | -8.46 | - |
Change in Inventory | -21.65 | -7.33 | -0.4 | -5.62 | -7.51 | - |
Change in Accounts Payable | -8.48 | -1.69 | 2.23 | 3.15 | 1.57 | 0.25 |
Change in Other Net Operating Assets | 41.9 | 47.36 | 30.35 | -3.68 | 4.23 | 3.38 |
Operating Cash Flow | 39.31 | -5.63 | -112.16 | -247.06 | -257.72 | -174.63 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.16 | -0.69 | -0.14 | -0.43 | -0.33 | -1 |
Sale (Purchase) of Intangibles | - | -10 | -5 | - | -22.95 | - |
Investment in Securities | -85.82 | -19.57 | 33.96 | 180.66 | -63.92 | -74.96 |
Investing Cash Flow | -85.98 | -30.25 | 28.82 | 180.23 | -87.2 | -75.95 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | 125 | 73.99 |
Long-Term Debt Repaid | - | - | -100 | - | - | - |
Net Debt Issued (Repaid) | - | - | -100 | - | 125 | 73.99 |
Issuance of Common Stock | 9.26 | 6.97 | 166.2 | 101.32 | 178.99 | 209.6 |
Other Financing Activities | -1 | - | - | - | -2.19 | -1.64 |
Financing Cash Flow | 8.26 | 6.97 | 66.2 | 101.32 | 301.8 | 281.95 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.2 | 0.17 | -0.24 | -0.05 | - | - |
Net Cash Flow | -38.62 | -28.74 | -17.37 | 34.45 | -43.12 | 31.37 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 39.15 | -6.31 | -112.3 | -247.49 | -258.05 | -175.62 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 8.44% | -1.68% | -57.14% | -415.20% | -7000.76% | - |
Free Cash Flow Per Share | 0.30 | -0.05 | -0.93 | -3.57 | -4.69 | -3.56 |
Levered Free Cash Flow | 21.69 | -15.7 | -72.9 | -152.09 | -195.81 | -102.77 |
Unlevered Free Cash Flow | 30.34 | -8.15 | -55.92 | -133.52 | -186.03 | -102.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 11.99 | 10.33 | 22.21 | 25.45 | 12.64 | 0.14 |
Change in Working Capital | -36.71 | -34.83 | -15.08 | -23.5 | -10.18 | 3.62 |